nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new glance at the role of traditional medicines in treatment of cancers
|
Shirzad, Meysam |
|
|
147 |
11 |
p. 3455-3456 |
artikel |
2 |
Anti-tumour effect of neo-antigen-reactive T cells induced by RNA mutanome vaccine in mouse lung cancer
|
Sun, Jiaxing |
|
|
147 |
11 |
p. 3255-3268 |
artikel |
3 |
A tumor microenvironment-related mRNA–ncRNA signature for prediction early relapse and chemotherapeutic sensitivity in early-stage lung adenocarcinoma
|
Gao, Zhendong |
|
|
147 |
11 |
p. 3195-3209 |
artikel |
4 |
Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma
|
Wang, Qian |
|
|
147 |
11 |
p. 3441-3445 |
artikel |
5 |
Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine–cisplatin and high dose-intensity MVAC
|
Lee, Yongjune |
|
|
147 |
11 |
p. 3421-3429 |
artikel |
6 |
Correction to: Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways
|
Zheng, Tongsen |
|
|
147 |
11 |
p. 3457-3458 |
artikel |
7 |
Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma
|
Barrau, Mathilde |
|
|
147 |
11 |
p. 3447-3454 |
artikel |
8 |
Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis
|
Sternschuss, Michal |
|
|
147 |
11 |
p. 3369-3379 |
artikel |
9 |
Ernst von Leyden (1832–1910): a pioneer in making oncology a respected medical discipline
|
Voswinckel, Peter |
|
|
147 |
11 |
p. 3325-3331 |
artikel |
10 |
Eukaryotic initiation factor-2, gamma subunit, suppresses proliferation and regulates the cell cycle via the MAPK/ERK signaling pathway in acute myeloid leukemia
|
Lu, Jielun |
|
|
147 |
11 |
p. 3157-3168 |
artikel |
11 |
FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression
|
Su, Yiming |
|
|
147 |
11 |
p. 3225-3243 |
artikel |
12 |
Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer
|
Yang, Zhao |
|
|
147 |
11 |
p. 3279-3288 |
artikel |
13 |
Gut microbiota-derived metabolites in CRC progression and causation
|
Dalal, Nishu |
|
|
147 |
11 |
p. 3141-3155 |
artikel |
14 |
Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival
|
Schmidt, Andreas |
|
|
147 |
11 |
p. 3169-3181 |
artikel |
15 |
Increased interleukin-17A-producing γδT cells predict favorable survival in elderly patients with LUAD and LUSC
|
Cui, Kele |
|
|
147 |
11 |
p. 3289-3298 |
artikel |
16 |
Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1
|
Troschel, Fabian M. |
|
|
147 |
11 |
p. 3299-3312 |
artikel |
17 |
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases
|
Cuccia, Francesco |
|
|
147 |
11 |
p. 3269-3277 |
artikel |
18 |
Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation
|
Wang, Yu-Jin |
|
|
147 |
11 |
p. 3245-3254 |
artikel |
19 |
Patient assessment and feasibility of treatment in older patients with cancer: results from the IN-GHO® Registry
|
Honecker, Friedemann |
|
|
147 |
11 |
p. 3183-3194 |
artikel |
20 |
Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries
|
Efremov, Ljupcho |
|
|
147 |
11 |
p. 3381-3390 |
artikel |
21 |
Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC)
|
Hubscher, Elizabeth |
|
|
147 |
11 |
p. 3359-3368 |
artikel |
22 |
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy: VinoMetro—AGO-B-046
|
Krajnak, Slavomir |
|
|
147 |
11 |
p. 3391-3400 |
artikel |
23 |
Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression
|
Gundlach, Jan-Paul |
|
|
147 |
11 |
p. 3313-3324 |
artikel |
24 |
Regulation of prognosis-related Siglecs in the glioma microenvironment
|
Mao, Rui |
|
|
147 |
11 |
p. 3343-3357 |
artikel |
25 |
Self-medication with herbal medicine and breast cancer survival: a prospective monocentric study
|
Ben Kridis, Wala |
|
|
147 |
11 |
p. 3401-3407 |
artikel |
26 |
SWI/SNF chromatin remodeling complex alterations in meningioma
|
Gill, Corey M. |
|
|
147 |
11 |
p. 3431-3440 |
artikel |
27 |
The association of immunosurveillance and distant metastases in colorectal cancer
|
Jacob, Sven |
|
|
147 |
11 |
p. 3333-3341 |
artikel |
28 |
The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time
|
Ono, Mayu |
|
|
147 |
11 |
p. 3211-3224 |
artikel |
29 |
Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study
|
Knight, Katrina A. |
|
|
147 |
11 |
p. 3409-3420 |
artikel |